Posters

Filters

Clear Filters
All Days Sun, Sep 28 Mon, Sep 29 Tue, Sep 30

Sunday, September 28

4:45 PM - 6:00 PM PT

2501 - Cranial Radiotherapy Improves Survival in Brain Metastatic NSCLC Patients Bearing EGFR and TP53 Mutations
Speaker: WANG, LU, MD, PhD - Department of radiotherapy oncology, Chongqing University Cancer Hospital & Chongqing Cancer Institute & Chongqing Cancer Hospital, chongqing
4:45 PM - 6:00 PM PT

2502 - Clinical and Dosimetric Predictors of Radiation Pneumonitis in Pathologic Stage III-N2 Non-Small Cell Lung Cancer Patients Receiving Postoperative Radiotherapy Following Lobectomy: An Analysis of a Prospective Cohort
Speaker: Wang, Nengyang, MD - Shanghai Chest Hospital Shanghai Jiao Tong University, Shanghai, Shanghai
4:45 PM - 6:00 PM PT

2504 - Exploration on Perioperative Treatment Strategies of Driver Gene-Positive Resectable Non-Small Cell Lung Cancer
Speaker: Wang, Xingpeng, MD - School of Clinical Medicine, Shandong Second Medical University, Jinan, Shandong
4:45 PM - 6:00 PM PT

2505 - Comparison of Changes in Pulmonary Function after SBRT vs. Surgery for Early-Stage Non-Small Cell Lung Cancer: A Prospective Real-World Observational Study
Speaker: Wang, Yue, Grad Student - Tianjin Medical University Cancer Institute and Hospital, Tianjin, Tianjin
4:45 PM - 6:00 PM PT

2506 - Enhanced Survival in Stage IV NSCLC Patients: A Comparison of Sequential vs. Concurrent Radiotherapy Combined with Immunotherapy
Speaker: Wang, Yuqi, MD, RT - Shandong Provincial Key Laboratory of Radiation Oncology, Shandong Cancer Hospital and Institute, Shandong First Medical University and Shandong Academy of Medical-Sciences, Jinan, Shangdong
4:45 PM - 6:00 PM PT

2507 - Clinical Features and Treatment Outcomes of Pediatric Abdominal and Pelvic Rhabdomyosarcoma
Speaker: Wang, Yuqing, MD - Radiation Oncology Center, Chongqing University Cancer Hospital, Chongqing, Chongqing
4:45 PM - 6:00 PM PT

2508 - Factors Associated with Prostate Cancer Survivors' Engagement in the Community, Results from a Population-Based Cohort
Speaker: Watts, Shelby, BS - University of Kansas Medical Center, Kansas City, KS
4:45 PM - 6:00 PM PT

2509 - Evaluating [<sup>18</sup>F]Fluorodeoxyglucose (FDG) Uptake as a Prognostic Metric in Stage IV Lung Cancer Patients Being Treated with Pharmacological Ascorbate and Chemotherapy
Speaker: Way, Ashley, MD - University of Iowa Hospitals & Clinics, Iowa City, IA
4:45 PM - 6:00 PM PT

2510 - Leveraging Nanomechanical Signatures as Predictive Biomarkers for Radiation Therapy Guidance in Advanced Solid Tumors
Speaker: Welsh, James, MD - Professor, Houston , Texas
4:45 PM - 6:00 PM PT

2511 - Reirradiation or Repeat Organ Irradiation for Non-Small Cell Lung Cancer: Oncological Outcomes and Toxicities
Speaker: Willmann, Jonas, MD - University Hospital Zurich, Kilchberg, Zurich
4:45 PM - 6:00 PM PT

2512 - Examining Treatment and Outcome Disparities in Lung Cancer Among Northern Plains American Indians and Non-Indigenous Populations
Speaker: Wilson, Peter, MD - University of Minnesota, Minneapolis, MN
4:45 PM - 6:00 PM PT

2513 - Variation in Treatment Time and On-Board Imaging for Lung Tumors by Motion Management Technique: A Secondary Analysis of the iSABR Trial
Speaker: Worth, John, BS - Stanford University, Palo Alto, CA